327 related articles for article (PubMed ID: 16418486)
1. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
[TBL] [Abstract][Full Text] [Related]
2. p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways.
Buganim Y; Solomon H; Rais Y; Kistner D; Nachmany I; Brait M; Madar S; Goldstein I; Kalo E; Adam N; Gordin M; Rivlin N; Kogan I; Brosh R; Sefadia-Elad G; Goldfinger N; Sidransky D; Kloog Y; Rotter V
Cancer Res; 2010 Mar; 70(6):2274-84. PubMed ID: 20197462
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
5. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
Kan CE; Patton JT; Stark GR; Jackson MW
Cancer Res; 2007 Oct; 67(20):9862-8. PubMed ID: 17942917
[TBL] [Abstract][Full Text] [Related]
6. Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation.
Logunov DY; Scheblyakov DV; Zubkova OV; Shmarov MM; Rakovskaya IV; Gurova KV; Tararova ND; Burdelya LG; Naroditsky BS; Ginzburg AL; Gudkov AV
Oncogene; 2008 Jul; 27(33):4521-31. PubMed ID: 18408766
[TBL] [Abstract][Full Text] [Related]
7. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
8. Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature.
Solomon H; Buganim Y; Kogan-Sakin I; Pomeraniec L; Assia Y; Madar S; Goldstein I; Brosh R; Kalo E; Beatus T; Goldfinger N; Rotter V
J Cell Sci; 2012 Jul; 125(Pt 13):3144-52. PubMed ID: 22427690
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
[TBL] [Abstract][Full Text] [Related]
10. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
11. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
12. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts.
Lenos K; de Lange J; Teunisse AF; Lodder K; Verlaan-de Vries M; Wiercinska E; van der Burg MJ; Szuhai K; Jochemsen AG
Mol Cancer; 2011 Sep; 10():111. PubMed ID: 21910853
[TBL] [Abstract][Full Text] [Related]
14. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
15. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
16. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
17. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumorigenesis by the p53 target PUMA.
Hemann MT; Zilfou JT; Zhao Z; Burgess DJ; Hannon GJ; Lowe SW
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9333-8. PubMed ID: 15192153
[TBL] [Abstract][Full Text] [Related]
19. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
20. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
